Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734822 · ClinicalTrials.gov registry record · NA
Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia
A NA study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03734822: Completed NA study, sponsored by Nationwide Children's Hospital.
NCT03734822 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03734822, a NA study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Four methods are routinely used to monitor CO2 in patients. End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia. CO2 is also monitored in other healthcare settings transcutaneously (TCO2), via finger stick capillary CO2 (CapCO2), and arterial blood gas (ABG). The purpose of this study is to perform all four measurements simultaneously during general anesthesia to identify which measure provides the most accurate data with the least amount of patient risk.
Primary Outcome
Looking at the accuracy of CO2 levels assessed via end tidal CO2 (ETCO2), capillary CO2 (Cap-CO2), and transcutaneous CO2 (TCCO2) compared to arterial blood gas (ABG) which is the gold standard.
Interventions
- OTHER End tidal CO2 (EtCO2)
- DEVICE Transcutaneous CO2 (TCO2)
- DIAGNOSTIC_TEST Capillary CO2 (CapCO2)
- DIAGNOSTIC_TEST Arterial blood gas (ABG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-03-10 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
What the finished NCT03734822 record still lists
NCT03734822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which End tidal CO2 (EtCO2) is the first listed.
NCT03734822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03734822 about?
NCT03734822 is a clinical study titled "Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia". Four methods are routinely used to monitor CO2 in patients. End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia. CO2 is also monitored in other healthcare settings transcutaneously (TCO2), via finger stick capillary CO2 (CapCO2), and arterial blood gas (ABG). T...
What is the current status of trial NCT03734822?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2016-03-10. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT03734822?
The interventions under investigation include: End tidal CO2 (EtCO2) (OTHER), Transcutaneous CO2 (TCO2) (DEVICE), Capillary CO2 (CapCO2) (DIAGNOSTIC_TEST), Arterial blood gas (ABG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03734822?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03734822's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI